BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15448696)

  • 1. Identification of BRCA1-IRIS, a BRCA1 locus product.
    ElShamy WM; Livingston DM
    Nat Cell Biol; 2004 Oct; 6(10):954-67. PubMed ID: 15448696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
    Nakuci E; Mahner S; Direnzo J; ElShamy WM
    Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region.
    Marino M; Rabacchi C; Simone ML; Medici V; Cortesi L; Calandra S
    Clin Chim Acta; 2009 May; 403(1-2):249-53. PubMed ID: 19393826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein DeltaBRCA1(17aa).
    Liu J; Prolla G; Rostagno A; Chiarle R; Feiner H; Inghirami G
    Oncogene; 2000 May; 19(23):2767-73. PubMed ID: 10851077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter usage of BRCA1-IRIS.
    Kvist A; Rovira C; Borg A; Medstrand P
    Nat Cell Biol; 2005 Apr; 7(4):325-6; author rply 326. PubMed ID: 15803125
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
    Au WW; Henderson BR
    Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel BRCA1 gene mutations in breast cancer patients from St. Petersburg].
    Tikhomirova OS; Grudinina NA; Golubkov VI; Mandel'shtam MIu; Vasil'ev BV
    Genetika; 2007 Sep; 43(9):1263-8. PubMed ID: 17990525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms.
    Pettigrew C; Wayte N; Lovelock PK; Tavtigian SV; Chenevix-Trench G; Spurdle AB; Brown MA
    Breast Cancer Res; 2005; 7(6):R929-39. PubMed ID: 16280041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refocusing on BRCA1.
    Ashworth A
    Nat Cell Biol; 2004 Oct; 6(10):916-7. PubMed ID: 15459717
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and functional analysis of novel BRCA1 transcripts, including mouse Brca1-Iris and human pseudo-BRCA1.
    Pettigrew CA; French JD; Saunus JM; Edwards SL; Sauer AV; Smart CE; Lundström T; Wiesner C; Spurdle AB; Rothnagel JA; Brown MA
    Breast Cancer Res Treat; 2010 Jan; 119(1):239-47. PubMed ID: 19067158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterisation of a soluble N-terminal fragment of the breast cancer susceptibility protein BRCA1.
    Sturdy A; Naseem R; Webb M
    J Mol Biol; 2004 Jul; 340(3):469-75. PubMed ID: 15210348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 in breast and ovarian cancer predisposition.
    Billack B; Monteiro AN
    Cancer Lett; 2005 Sep; 227(1):1-7. PubMed ID: 16051027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo.
    Quaresima B; Romeo F; Faniello MC; Di Sanzo M; Liu CG; Lavecchia A; Taccioli C; Gaudio E; Baudi F; Trapasso F; Croce CM; Cuda G; Costanzo F
    Clin Cancer Res; 2008 Nov; 14(21):6797-803. PubMed ID: 18980973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of BRCA1 and BRCA2 mutations from Korean breast cancer patients using denaturing HPLC.
    Kim BY; Lee DG; Lee KR; Han SH; Surendran S; Han CW; Chung N
    Biochem Biophys Res Commun; 2006 Oct; 349(2):604-10. PubMed ID: 16949048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of two evolutionarily conserved and functional regulatory elements in intron 2 of the human BRCA1 gene.
    Wardrop SL; Brown MA;
    Genomics; 2005 Sep; 86(3):316-28. PubMed ID: 15990270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
    Cousineau I; Abaji C; Belmaaza A
    Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.